MedTrace Logo

Micronutrient Supplement for Nurse Burnout

NCT05363410 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2022-05-05

No results posted yet for this study

Summary

The purpose of this study is to confirm and quantify the ability of an 8-week intervention with a supplement containing magnesium citrate and vitamin B6 to reduce anxiety, stress, and burnout among nurses working full time in hospitals and urgent care centers during the COVID-19 Pandemic.

Conditions

  • Burnout, Professional
  • Stress, Psychological

Interventions

DIETARY_SUPPLEMENT

MagnéVie B6®

micronutrient supplement

OTHER

Placebo

placebo supplement

Sponsors & Collaborators

  • Opella Healthcare Group SAS, a Sanofi Company

    collaborator INDUSTRY

  • Nutraceuticals Research Institute

    lead OTHER

Principal Investigators

  • JESSIE HAWKINS, PhD · Nutraceuticals Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-09-30
Completion
2023-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05363410 on ClinicalTrials.gov